Wyeth mulls restructuring its global sales force

Share this article:
Wyeth said the restructuring of its U.S. sales force was only a start and that it is considering making similar changes globally.
"Obviously it is a first step. We're also looking internationally. Our European affiliates have started to look at how to optimize the sales force," Bernard Poussot, head of Wyeth's pharmaceutical operations, said in a Financial Times report.
Last month Wyeth said it would use inside, part-time sales representatives in the U.S. to complement its full-time sales force, which is being reduced by about 25% to 30%.
Adding the part-timers will result in a net sales-force reduction of about 15%, Poussot said. Wyeth has deployed part-timers in its consumer division for the past few years.
As reported in MM&M (July 2005), the drug maker began piloting part-timers in its pharmaceuticals division in July and said it will fully implement them by year's end.
Share this article:

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.